Hormonal steroids could make gonorrhea untreatable

You know that package warning that oral birth control won’t prevent STIs? Well in the case of gonorrhea, the sexually transmitted bacterium that causes the disease can use those hormones to help it resist antibiotic attacks.

Innovent details Phase 3 weight loss data from Lilly-partnered GLP-1 in Chinese patients

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 15, 2024

ASCO 24: Sanofi’s Sarclisa looks to gain an edge in multiple myeloma – Pharmaceutical Technology

Sarclisa is a CD38-directed cytolytic human monoclonal antibody that received its first FDA approval for the treatment of adults with previously multiple myeloma. Credits: nitpicker

June 4, 2024

Personalized Intervention Helps CRC Screening Decisions for Older Adults

Older adults given personalized information about the benefits and risks of screening for colorectal cancer (CRC) were more likely to receive screening orders that were

November 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.